Medical Services Expenditures by Disease: Diseases of the Musculoskeletal System and Connective Tissue, MEPS Account Basis (DIMSCTEXPMEPS) | FRED | St. Louis Fed
- Rows
- 22
- Columns
- 2
- Data range
- 2000-01-01 to 2021-01-01
Graph and download economic data for Medical Services Expenditures by Disease: Diseases of the Musculoskeletal System and Connective Tissue, MEPS Account Basis (DIMSCTEXPMEPS) from 2000 to 2021 about connective tissue, musculoskeletal, disease, healthcare, medical, health, expenditures, services, and USA.
AI analysis
Dataset Analysis: Medical Services Expenditures — Musculoskeletal & Connective Tissue Disease (MEPS)
1. What this dataset represents
This series, sourced from the St. Louis Fed's FRED platform (fredgraph.csv?id=DIMSCTEXPMEPS), tracks annual U.S. medical services expenditures attributable to diseases of the musculoskeletal system and connective tissue, drawn from the Medical Expenditure Panel Survey (MEPS) account basis. FRED aggregates this from federal survey data (likely AHRQ/MEPS originally), making it a credible, publicly-vetted time series suitable for economic and healthcare research. With annual observations spanning 2000–2021, it offers a 22-year macro view of disease-specific healthcare cost burden — valuable for correlation studies examining how musculoskeletal disease costs relate to aging population trends, obesity rates, opioid/pain-management prescribing patterns, occupational injury statistics, or broader healthcare inflation indices also hosted on FRED.
2. Data quality observations
The dataset is exceptionally clean at face value: zero null cells across both columns, and both observationdate and DIMSCTEXPMEPS show 22 distinct values matching the 22 total rows — meaning every year 2000–2021 has exactly one unique observation with no duplication. However, the duplicate-row check is flagged as "pending Phase D recomputation," so this should be formally reconfirmed against the Parquet backend before treating the dataset as fully validated. No type mismatches are reported, and the annual granularity (one row per year) means there's little room for within-year noise, but also limits the dataset's resolution for higher-frequency correlation work (e.g., against quarterly GDP or monthly CPI).
3. Key columns and distributions
The sole value column, DIMSCTEXPMEPS, ranges from a minimum of $77.49 to a maximum of $321.62 (likely in billions), a more than 4x spread over the observation window — suggesting substantial real growth in musculoskeletal disease expenditures over two decades. The mean (192.25) sits above the median (184.10), and the modest positive skew (0.304) indicates a slight right tail, consistent with expenditures accelerating in later years rather than growing linearly. The interquartile range (Q1=121.12, Q3=256.23) spans roughly 135 units, reinforcing that half the observations are clustered across a wide-cost band — again pointing to a strong upward trend rather than stable variance. No outlier counts are flagged, and the tight distinct=22/rows=22 relationship confirms no repeated values, typical of a monotonic or near-monotonic economic growth series.
4. Recommended join keys
observationdate is the clear and only viable join key — it's a clean annual date field with zero nulls and full distinctness. For cross-dataset correlation, this should be joined on year (extracting YYYY from the date) against other annual or resampled-to-annual FRED series, since this dataset's granularity won't support monthly/quarterly joins without aggregation or interpolation on the other side.
5. Suggested pairings for correlation discovery
Strong candidates include other MEPS disease-expenditure series (e.g., circulatory, respiratory, or mental health disorders) to compare relative disease-cost growth trajectories; CPI for Medical Care Services or the Personal Health Care Expenditure deflator to assess whether growth is real or inflation-driven; BLS obesity/chronic condition prevalence data or CDC arthritis/back pain prevalence statistics as plausible demand-side drivers; U.S. population aging metrics (e.g., median age, 65+ population share) given musculoskeletal disease's strong age correlation; and labor market indicators like workers' compensation claims or occupational injury rates, which may share a causal or coincident relationship with connective tissue disease costs.
Columns
- observation_date (date)
- DIMSCTEXPMEPS (decimal)